(12) United States Patent (10) Patent No.: US 8,883,481 B2 Dormitzer Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) United States Patent (10) Patent No.: US 8,883,481 B2 Dormitzer Et Al USOO8883481 B2 (12) United States Patent (10) Patent No.: US 8,883,481 B2 Dormitzer et al. (45) Date of Patent: Nov. 11, 2014 (54) REVERSE GENETICS METHODS FOR VIRUS (56) References Cited RESCUE U.S. PATENT DOCUMENTS (75) Inventors: Philipso Dormitzer, Weston, MA (US); 6,455,298 B1* 9/2002 Groner et al. .............. 435/235.1 Björn Keiner, Marburg (DE); Pirada 2008/O124803 A1 5/2008 Billeter et al. Suphaphiphat, Brookline, MA (US); Michael Franti, Quebec (CA); Peter FOREIGN PATENT DOCUMENTS Mason, Sommerville, MA (US); WO WO-2003/091401 4/2003 ennifer Uhlendorff, Neuss (DE): WO WO-2005/062820 7/2005 Mikhail Matrosovich, Marburg (DE) WO WO-2007/047459 7/2005 WO WO-2010/046335 4/2010 (73) Assignee: Novartis AG, Basel (CH) OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer the term of this Wang et al. Cloning of the canine RNA polymerase I promoter and patent is extended or adjusted under 35 establishment of reverse genetics for influenza A and B in MDCK U.S.C. 154(b) by 17 days. cells. Virology Journal 2007, vol. 4, p. 102-113.* Nicolson et al. Generation of influenza vaccine viruses on Vero cells (21) Appl. No.: 13/503,353 by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 2005, vol. 23, pp. 2943-2952.* Koudstaal et al. (Apr. 28, 2009). "Suitability of PerC6 cells to gen (22) PCT Filed: Oct. 20, 2010 erate epidemic and pandemic influenza vaccine strains by reverse genetics.” Vaccine 27(19):2588-93. (86). PCT No.: PCT/B2010/054752 Neumann (2003). “Reverse genetics for the control of avian influ enza.” Avian Dis. 47(3 Suppl):882-7. S371 (c)(1), Suphaphiphatet al. (Apr. 2010). “Human RNA Polymerase I-Driven (2), (4) Date: Oct. 11, 2012 Reverse Genetics for Influenza A Virus in Canine Cells.' J. Virol. vol. 84 No. 73721-3725. (87) PCT Pub. No.: WO2011/048560 Whiteleyetal. (Jul. 2007). "Generation of candidate human influenza vaccine strains in cell culture—rehearsing the European response to PCT Pub. Date: Apr. 28, 2011 an H7N1 pandemic threat.” Influenza. Other RespiViruses. 1(4): 157 66. (65) Prior Publication Data Zhang et al. (Sep. 2009). "A one-plasmid system to generate influ enza virus in cultured chicken cells for potential use in influenza US 2013/0034582 A1 Feb. 7, 2013 vaccine.” JVirol. 83(18):9296-303. International Search Report mailed on Feb. 21, 2012, for Interna tional Patent Application No. PCT/IB2010/054752, filed on Oct. 20, Related U.S. ApplicationO O Data International2010. Preliminary Report on Patentability mailed on Jul. 27. (60) Provisional application No. 61/279.487, filed on Oct. 2012, for International Patent Application No. PCT/IB2010/054752, 20, 2009. filed on Oct. 20, 2010. s Xuan, Bai (2008). “The Construction of Rotavirus Group a Reassort ment strain by Reverse Genetics.” China Master's Thesis Full Text (51) Int. Cl. Database, No. 12. Available online at <http://www.dissertationtopic. CI2N 7/00 (2006.01) net? doc/1470 105>. CI2N 7/02 (2006.01) A6 IK39/45 (2006.01) * cited by examiner (52) U.S. Cl. CPC ........ CI2N 7/00 (2013.01); C12N 2760/16151 Primary Examiner — Louise Humphrey (2013.01) (74) Attorney, Agent, or Firm — Atsuko Polzin; Otis USPC ...................... 435/239; 435/235.1; 424/206.1 Littlefield (58) Field of Classification Search CPC ........... C12N 7/00; C12N 2760/16151; C12N (57) ABSTRACT 2760/16251; C12N 2760/16152; C12N A method for rescuing a virus by reverse genetics is provided 2760/16252; C12N 2760/16134; C12N in which cells are added after transfection. 2760/16234: A61K 39/145 See application file for complete search history. 8 Claims, 4 Drawing Sheets U.S. Patent Nov. 11, 2014 Sheet 1 of 4 US 8,883,481 B2 FGURE O ?ae?***…×××××××××××××××, %. U.S. Patent Nov. 11, 2014 Sheet 2 of 4 US 8,883,481 B2 FGURE 2 ---------------------------|90+=00|| –––.Z0+='00"| U.S. Patent Nov. 11, 2014 Sheet 3 of 4 US 8,883,481 B2 FIGURE 3 U.S. Patent Nov. 11, 2014 Sheet 4 of 4 US 8,883,481 B2 FGURE 4 ------------'-- - - - - - - - - - - - --------------------------------------------------.l . YY YYYYYYYYYYYYYYYYYY YYYYYY 33YYYX Y33. US 8,883,481 B2 1. 2 REVERSE GENETCS METHODS FOR VIRUS mixture of cells; (iii) culturing the mixture of cells in order to RESCUE produce virus; (iv) purifying the virus obtained in step (iii) and optionally (V) formulating the virus into a vaccine. CROSS REFERENCE TO RELATED Reverse Genetics APPLICATIONS Reverse genetics can be used for the production of a wide variety of RNA viruses, including positive-strand RNA This application is a U.S. National Phase patent application viruses 1.2, negative-strand RNA viruses 3,4 and double of PCT/IB2010/054752, filed Oct. 20, 2010, which claims stranded RNA viruses 5. Thus, the present invention pro priority to U.S. provisional patent application Ser. No. vides a method for producing a recombinant virus wherein 10 the virus is obtained using the reverse genetics method of the 61/279,487 filed Oct. 20, 2009, all of which are hereby incor present invention. porated by reference in the present disclosure in their entirety. Known reverse genetics systems involve expressing DNA SUBMISSION OF SEQUENCE LISTING AS molecules which encode desired viral. RNA (VRNA) mol ASCII TEXT FILE ecules from pol I promoters, bacterial RNA polymerase pro 15 moters, bacteriophage polymerase promoters, etc. Further The content of the following submission on ASCII text file more, where a virus requires certain proteins to form an is incorporated herein by reference in its entirety: a computer infectious virus, the systems also provide these proteins e.g. readable form (CRF) of the Sequence Listing (file name: the system further comprises DNA molecules that encode 223.002124600SeqList.txt, date recorded: Apr. 13, 2012, size: viral proteins such that expression of both types of DNA leads 18 KB). to assembly of a complete infectious virus. Where reverse genetics is used for the expression of vRNA, TECHNICAL FIELD it will be evident to the person skilled in the art that precise spacing of the sequence elements with reference to each other This invention is in the field of reverse genetics. Further is pivotal for the polymerase to initiate replication. It is there more, it relates to manufacturing vaccines for protecting 25 fore important that the DNA molecule encoding the viral against various viruses. RNA is positioned correctly between the pol I promoter and the termination sequence, but this positioning is well within BACKGROUND ART the capabilities of those who work with reverse genetics sys temS. Reverse genetics permits the recombinant expression and 30 Generally, reverse genetics is suitable for expression of any manipulation of RNA viruses in cell culture. It is a powerful viruses which are known to require production of genomic tool in Virology and vaccine manufacture because it allows RNA during their life-cycle. Such viruses include, but are not rapid production of recombinant viruses (including reassor limited to, positive-strand and negative-strand RNA viruses, tants) and/or their mutation. The method involves transfect such as those described below. Preferably, the virus is an ing host cells with one or more expression constructs that 35 orthomyxovirus, e.g., an influenza virus. The methods of the encode the viral genome and isolating the virus from the cells. invention are further suitable for non-segmented as well as One drawback with virus rescue by reverse genetics is that segmented viruses. the process is inefficient and frequently results in an unsatis Where the virus is a positive-strand RNA virus it is often factory virus yield. Thus there remains a need in the art to Sufficient to transfect a cell with an expression construct provide alternative and more efficient reverse genetics meth 40 comprising the viral genome. For example, the transfection of ods. plasmids containing the poliovirus genome resulted in the recovery of infectious poliovirus 1.2. Reverse genetics for SUMMARY OF PREFERREDEMBODIMENTS negative-strand RNA viruses has presented more challenges as the antisense viral RNA is usually non-infective and The inventors have now surprisingly discovered that the 45 requires an RNA polymerase to complete the life cycle. Thus, poor efficiency of reverse genetics methods can be improved the viral polymerase must be supplied, either as protein or as significantly by transfecting cells with the reverse genetics a gene for in situ protein expression. construct(s) and Subsequently adding more cells to the trans Where the virus requires a protein for infectivity, it is fected cells. The inventors surmise that the observed increase generally preferred to use bi-directional expression con in efficiency is due to the fact that transfection is harmful to 50 structs as this reduces the total number of expression con the cells. Thus, any viruses which are rescued need to expand structs required by the host cell. Thus, the method of the in sick cells or wait until the virus is transferred to healthy invention may utilise at least one bi-directional expression cells. This results in a loss of viable virus. The addition of construct wherein a gene or cDNA is located between an cells to the transfected host cells allows the rescued virus to upstreampol II promoter and a downstream non-endogenous multiply on a healthy cell substrate which increases the virus 55 pol I promoter. Transcription of the gene or cDNA from the yield significantly. pol II promoter produces capped positive-sense viral mRNA In one embodiment, the invention provides a method for which can be translated into a protein, while transcription preparing a virus comprising the steps of (i) transfecting a from the non-endogenous pol I promoter produces negative culture of host cells with at least one expression construct sense VRNA.
Recommended publications
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • Detección De Agentes Virales En Ostión Japonés (Crassostrea Gigas)
    CENTRO DE INVESTIGACIONES BIOLÓGICAS DEL NOROESTE, S. C. Programa de Estudios de Posgrado Detección de agentes virales en ostión Japonés (Crassostrea gigas) T E S I S Que para obtener el grado de Doctor en Ciencias Uso, Manejo y Preservación de los Recursos Naturales (Orientación en: Biotecnología) p r e s e n t a Valérie Barbosa Solomieu La Paz, B. C. S.,(Junio-2004) COMITE TUTORIAL Dr. Ricardo Vázquez Juárez (co-director) CIBNOR, La Paz, Mexico Dr. Felipe Ascencio Valle (co-director) CIBNOR, La Paz, Mexico Dr. Tristan Renault (tutor) IFREMER, La Tremblade, France Dr. Ralph Elston (tutor) AQUATECHNICS, INC., Seattle, USA Dr. Jorge de la Rosa Vélez (tutor) UABC, Ensenada, Mexico COMISION REVISORA Dr. Ricardo Vázquez Juárez CIBNOR Dr. Felipe Ascencio Valle CIBNOR Dr. Tristan Renault IFREMER, France Dr. Ralph Elston AQUATECHNICS, INC., USA Dr. Jorge de la Rosa Vélez UABC JURADO Dr. Ricardo Vázquez Juárez CIBNOR Dr. Felipe Ascencio Valle CIBNOR Dr. Ralph Elston AQUATECHNICS, INC. Dr. Humberto Villarreal Colmenares CIBNOR Dr. Dariel Tovar Ramírez CIBNOR Suplente Dr. Pedro Enrique Saucedo Lastra CIBNOR PROLOGO Y DEDICATORIA A mi madre, por estar siempre presente, a pesar de las distancias y los oceános… A mi padre, con quién habría querido compartir estos momentos y muchos más. A mis abuelos, quienes nunca han dejado de apoyarme, con todo mi cariño. A mi hermano y su esposa, parte de nuestra pequeña y dispersa familia. A todos aquellos que estuvieron a lo largo de este camino para iluminarlo con una sonrisa o una mano tendida. A quienes llenaron de magia y de alegría estos años.
    [Show full text]
  • Detection and Characterization of a Novel Marine Birnavirus Isolated from Asian Seabass in Singapore
    Chen et al. Virology Journal (2019) 16:71 https://doi.org/10.1186/s12985-019-1174-0 RESEARCH Open Access Detection and characterization of a novel marine birnavirus isolated from Asian seabass in Singapore Jing Chen1†, Xinyu Toh1†, Jasmine Ong1, Yahui Wang1, Xuan-Hui Teo1, Bernett Lee2, Pui-San Wong3, Denyse Khor1, Shin-Min Chong1, Diana Chee1, Alvin Wee1, Yifan Wang1, Mee-Keun Ng1, Boon-Huan Tan3 and Taoqi Huangfu1* Abstract Background: Lates calcarifer, known as seabass in Asia and barramundi in Australia, is a widely farmed species internationally and in Southeast Asia and any disease outbreak will have a great economic impact on the aquaculture industry. Through disease investigation of Asian seabass from a coastal fish farm in 2015 in Singapore, a novel birnavirus named Lates calcarifer Birnavirus (LCBV) was detected and we sought to isolate and characterize the virus through molecular and biochemical methods. Methods: In order to propagate the novel birnavirus LCBV, the virus was inoculated into the Bluegill Fry (BF-2) cell line and similar clinical signs of disease were reproduced in an experimental fish challenge study using the virus isolate. Virus morphology was visualized using transmission electron microscopy (TEM). Biochemical analysis using chloroform and 5-Bromo-2′-deoxyuridine (BUDR) sensitivity assays were employed to characterize the virus. Next-Generation Sequencing (NGS) was also used to obtain the virus genome for genetic and phylogenetic analyses. Results: The LCBV-infected BF-2 cell line showed cytopathic effects such as rounding and granulation of cells, localized cell death and detachment of cells observed at 3 to 5 days’ post-infection.
    [Show full text]
  • ICTV Code Assigned: 2011.001Ag Officers)
    This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the separate document “Help with completing a taxonomic proposal” Please try to keep related proposals within a single document; you can copy the modules to create more than one genus within a new family, for example. MODULE 1: TITLE, AUTHORS, etc (to be completed by ICTV Code assigned: 2011.001aG officers) Short title: Change existing virus species names to non-Latinized binomials (e.g. 6 new species in the genus Zetavirus) Modules attached 1 2 3 4 5 (modules 1 and 9 are required) 6 7 8 9 Author(s) with e-mail address(es) of the proposer: Van Regenmortel Marc, [email protected] Burke Donald, [email protected] Calisher Charles, [email protected] Dietzgen Ralf, [email protected] Fauquet Claude, [email protected] Ghabrial Said, [email protected] Jahrling Peter, [email protected] Johnson Karl, [email protected] Holbrook Michael, [email protected] Horzinek Marian, [email protected] Keil Guenther, [email protected] Kuhn Jens, [email protected] Mahy Brian, [email protected] Martelli Giovanni, [email protected] Pringle Craig, [email protected] Rybicki Ed, [email protected] Skern Tim, [email protected] Tesh Robert, [email protected] Wahl-Jensen Victoria, [email protected] Walker Peter, [email protected] Weaver Scott, [email protected] List the ICTV study group(s) that have seen this proposal: A list of study groups and contacts is provided at http://www.ictvonline.org/subcommittees.asp .
    [Show full text]
  • Report: 19Th Annual Workshop of the National Reference Laboratories for Fish Diseases
    Report: 19th Annual Workshop of the National Reference Laboratories for Fish Diseases Copenhagen, Denmark May 27th-28th 2015 FISH positive staining for Rickettsia like Gill necrosis in Koi Carp SVCV CPE on EPC cell culture organism in sea bass brain Organised by the European Union Reference Laboratory for Fish Diseases National Veterinary Institute, Technical University of Denmark 1 Contents INTRODUCTION AND SHORT SUMMARY ..................................................................................................................4 PROGRAM .................................................................................................................................................................8 Welcome ................................................................................................................................................................ 12 SESSION I: .............................................................................................................................................................. 13 UPDATE ON IMPORTANT FISH DISEASES IN EUROPE AND THEIR CONTROL ......................................................... 13 OVERVIEW OF THE DISEASE SITUATION AND SURVEILLANCE IN EUROPE IN 2014 .......................................... 14 UPDATE ON FISH DISEASE SITUATION IN NORWAY .......................................................................................... 17 UPDATE ON FISH DISEASE SITUATION IN THE MEDITERRANEAN BASIN .......................................................... 18 PAST
    [Show full text]
  • Arenaviridae Astroviridae Filoviridae Flaviviridae Hantaviridae
    Hantaviridae 0.7 Filoviridae 0.6 Picornaviridae 0.3 Wenling red spikefish hantavirus Rhinovirus C Ahab virus * Possum enterovirus * Aronnax virus * * Wenling minipizza batfish hantavirus Wenling filefish filovirus Norway rat hunnivirus * Wenling yellow goosefish hantavirus Starbuck virus * * Porcine teschovirus European mole nova virus Human Marburg marburgvirus Mosavirus Asturias virus * * * Tortoise picornavirus Egyptian fruit bat Marburg marburgvirus Banded bullfrog picornavirus * Spanish mole uluguru virus Human Sudan ebolavirus * Black spectacled toad picornavirus * Kilimanjaro virus * * * Crab-eating macaque reston ebolavirus Equine rhinitis A virus Imjin virus * Foot and mouth disease virus Dode virus * Angolan free-tailed bat bombali ebolavirus * * Human cosavirus E Seoul orthohantavirus Little free-tailed bat bombali ebolavirus * African bat icavirus A Tigray hantavirus Human Zaire ebolavirus * Saffold virus * Human choclo virus *Little collared fruit bat ebolavirus Peleg virus * Eastern red scorpionfish picornavirus * Reed vole hantavirus Human bundibugyo ebolavirus * * Isla vista hantavirus * Seal picornavirus Human Tai forest ebolavirus Chicken orivirus Paramyxoviridae 0.4 * Duck picornavirus Hepadnaviridae 0.4 Bildad virus Ned virus Tiger rockfish hepatitis B virus Western African lungfish picornavirus * Pacific spadenose shark paramyxovirus * European eel hepatitis B virus Bluegill picornavirus Nemo virus * Carp picornavirus * African cichlid hepatitis B virus Triplecross lizardfish paramyxovirus * * Fathead minnow picornavirus
    [Show full text]
  • Evidence to Support Safe Return to Clinical Practice by Oral Health Professionals in Canada During the COVID-19 Pandemic: a Repo
    Evidence to support safe return to clinical practice by oral health professionals in Canada during the COVID-19 pandemic: A report prepared for the Office of the Chief Dental Officer of Canada. November 2020 update This evidence synthesis was prepared for the Office of the Chief Dental Officer, based on a comprehensive review under contract by the following: Paul Allison, Faculty of Dentistry, McGill University Raphael Freitas de Souza, Faculty of Dentistry, McGill University Lilian Aboud, Faculty of Dentistry, McGill University Martin Morris, Library, McGill University November 30th, 2020 1 Contents Page Introduction 3 Project goal and specific objectives 3 Methods used to identify and include relevant literature 4 Report structure 5 Summary of update report 5 Report results a) Which patients are at greater risk of the consequences of COVID-19 and so 7 consideration should be given to delaying elective in-person oral health care? b) What are the signs and symptoms of COVID-19 that oral health professionals 9 should screen for prior to providing in-person health care? c) What evidence exists to support patient scheduling, waiting and other non- treatment management measures for in-person oral health care? 10 d) What evidence exists to support the use of various forms of personal protective equipment (PPE) while providing in-person oral health care? 13 e) What evidence exists to support the decontamination and re-use of PPE? 15 f) What evidence exists concerning the provision of aerosol-generating 16 procedures (AGP) as part of in-person
    [Show full text]
  • Accepted Version
    Article The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production BAMPI, Carole, et al. Abstract The cellular tail-interacting 47-kDa protein (TIP47) acts positively on HIV-1 and vaccinia virus production. We show here that TIP47, in contrast, acts as a restriction factor for Sendai virus production. This conclusion is supported by the occurrence of increased or decreased virus production upon its suppression or overexpression, respectively. Pulse-chase metabolic labeling of viral proteins under conditions of TIP47 suppression reveals an increased rate of viral protein synthesis followed by increased incorporation of viral proteins into virus particles. TIP47 is here described for the first time as a viral restriction factor that acts by limiting viral protein synthesis. Reference BAMPI, Carole, et al. The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production. Virus Research, 2013, vol. 173, no. 2, p. 354-63 DOI : 10.1016/j.virusres.2013.01.006 PMID : 23348195 Available at: http://archive-ouverte.unige.ch/unige:28890 Disclaimer: layout of this document may differ from the published version. 1 / 1 Virus Research 173 (2013) 354–363 Contents lists available at SciVerse ScienceDirect Virus Research journa l homepage: www.elsevier.com/locate/virusres The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production a a,b,1 c,d Carole Bampi , Anne-Sophie Gosselin Grenet , Grégory Caignard
    [Show full text]
  • RNA Viruses in the Sea Andrew S
    REVIEW ARTICLE RNA viruses in the sea Andrew S. Lang1, Matthew L. Rise2, Alexander I. Culley3 & Grieg F. Steward3 1Department of Biology, Memorial University of Newfoundland, St John’s, NL, Canada; 2Ocean Sciences Centre, Memorial University of Newfoundland, St John’s, NL, Canada; and 3Department of Oceanography, University of Hawaii at Manoa, Honolulu, HI, USA Correspondence: Andrew S. Lang, Abstract Department of Biology, Memorial University of Newfoundland, St John’s, NL, Canada A1B Viruses are ubiquitous in the sea and appear to outnumber all other forms of 3X9. Tel.: 11 709 737 7517; fax: 11 709 737 marine life by at least an order of magnitude. Through selective infection, viruses 3018; e-mail: [email protected] influence nutrient cycling, community structure, and evolution in the ocean. Over the past 20 years we have learned a great deal about the diversity and ecology of the Received 31 March 2008; revised 29 July 2008; viruses that constitute the marine virioplankton, but until recently the emphasis accepted 21 August 2008. has been on DNA viruses. Along with expanding knowledge about RNA viruses First published online 26 September 2008. that infect important marine animals, recent isolations of RNA viruses that infect single-celled eukaryotes and molecular analyses of the RNA virioplankton have DOI:10.1111/j.1574-6976.2008.00132.x revealed that marine RNA viruses are novel, widespread, and genetically diverse. Discoveries in marine RNA virology are broadening our understanding of the Editor: Cornelia Buchen-Osmond ¨ biology, ecology, and evolution of viruses, and the epidemiology of viral diseases, Keywords but there is still much that we need to learn about the ecology and diversity of RNA RNA virus; virioplankton; virus diversity; marine viruses before we can fully appreciate their contributions to the dynamics of virus; virus ecology; aquaculture.
    [Show full text]
  • Report 21St Annual Workshop of the National Reference Laboratories for Fish Diseases
    Report 21st Annual Workshop of the National Reference Laboratories for Fish Diseases Kgs. Lyngby, Denmark May 30th – 31st 2017 Tilapia disease in commercial hybrid Red Mark Syndrome (RMS) in rainbow tilapia (Eyngor et al., 2014) trout Organised by the European Union Reference Laboratory for Fish Diseases, National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby Table of Contents Introduction and short summary ...................................................................................... 4 Programme ......................................................................................................................... 6 SESSION I: Update on important fish diseases and their control ............................... 10 Overview of the disease situation and surveillance in Europe in 2016 ......................................................................... 11 Update on fish disease situation in Norway 2016 ........................................................................................................ 14 Update on the disease situation in aquatic organisms in the Mediterranean ............................................................. 16 Aquaculture and disease threats in Australia with an update on Epizootic Haematopoietic Necrosis Virus (EHNV) .. 17 Working Groups: Perception on the impact and risk of infectious fish diseases in Europe .............................................................................................................................. 18 Working group’s summary ..........................................................................................................................................
    [Show full text]
  • Structure Unveils Relationships Between RNA Virus Polymerases
    viruses Article Structure Unveils Relationships between RNA Virus Polymerases Heli A. M. Mönttinen † , Janne J. Ravantti * and Minna M. Poranen * Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikki Biocenter 1, P.O. Box 56 (Viikinkaari 9), 00014 Helsinki, Finland; heli.monttinen@helsinki.fi * Correspondence: janne.ravantti@helsinki.fi (J.J.R.); minna.poranen@helsinki.fi (M.M.P.); Tel.: +358-2941-59110 (M.M.P.) † Present address: Institute of Biotechnology, Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Viikki Biocenter 2, P.O. Box 56 (Viikinkaari 5), 00014 Helsinki, Finland. Abstract: RNA viruses are the fastest evolving known biological entities. Consequently, the sequence similarity between homologous viral proteins disappears quickly, limiting the usability of traditional sequence-based phylogenetic methods in the reconstruction of relationships and evolutionary history among RNA viruses. Protein structures, however, typically evolve more slowly than sequences, and structural similarity can still be evident, when no sequence similarity can be detected. Here, we used an automated structural comparison method, homologous structure finder, for comprehensive comparisons of viral RNA-dependent RNA polymerases (RdRps). We identified a common structural core of 231 residues for all the structurally characterized viral RdRps, covering segmented and non-segmented negative-sense, positive-sense, and double-stranded RNA viruses infecting both prokaryotic and eukaryotic hosts. The grouping and branching of the viral RdRps in the structure- based phylogenetic tree follow their functional differentiation. The RdRps using protein primer, RNA primer, or self-priming mechanisms have evolved independently of each other, and the RdRps cluster into two large branches based on the used transcription mechanism.
    [Show full text]
  • Molecular Biology and Structure of a Novel Penaeid Shrimp Densovirus Elucidate Convergent Parvoviral Host Capsid Evolution
    Molecular biology and structure of a novel penaeid shrimp densovirus elucidate convergent parvoviral host capsid evolution Judit J. Pénzesa,b, Hanh T. Phama, Paul Chipmanb, Nilakshee Bhattacharyac, Robert McKennab, Mavis Agbandje-McKennab,1,2, and Peter Tijssena,1,2 aInstitut Armand-Frappier, Institut national de la recherche scientifique-Institut Armand-Frappier, Laval, QC H7V 1B7, Canada; bThe McKnight Brain Institute, University of Florida, Gainesville, FL 32610; and cInstitute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306 Edited by Kenneth I. Berns, University of Florida College of Medicine, Gainesville, FL, and approved July 8, 2020 (received for review April 27, 2020) The giant tiger prawn (Penaeus monodon) is a decapod crustacean isolated from both proto- and deuterostome invertebrates, mostly widely reared for human consumption. Currently, viruses of two insects and other arthropods (6–18). distinct lineages of parvoviruses (PVs, family Parvoviridae; subfamily To date, parvovirus crustacean pathogens comprise three Hamaparvovirinae) infect penaeid shrimp. Here, a PV was isolated distinct lineages with divergent genome organizations and tran- and cloned from Vietnamese P. monodon specimens, designated scription patterns. Cherax quadricarinatus DV, isolated from the Penaeus monodon metallodensovirus (PmMDV). This is the first freshwater red-clawed crayfish (Cherax quadricarinatus), has an member of a third divergent lineage shown to infect penaeid ambisense genome with a PLA2 domain and is now an assigned decapods. PmMDV has a transcription strategy unique among in- member of genus Aquambidensovirus of the Densovirinae (19). vertebrate PVs, using extensive alternative splicing and incorpo- Genera Hepanhamaparvovirus and Penstylhamaparvovirus are rating transcription elements characteristic of vertebrate-infecting members of subfamily Hamaparvovirinae, each with one species PVs.
    [Show full text]